title: An exploration of the relationship between placebo and homeopathy and the implications for clinical trial design.
abstract: Placebo appears to be a real neurobiological phenomenon that has evolved through the selection pressure to be able to heal ourselves. The complex language and social structures of humans means that we can attribute meaning to therapeutic encounters with culturally sanctioned authority figures and we can use our attachment to such figures to generate hope for recovery. Different mechanisms may be involved in the neurobiological aspect of placebo including anxiety, learning, conditioning as well as individual genetic variation. Examination of the published work shows that while some trials do seem to indicate a specific mode of action for homeopathic remedies other trials do not and this is an issue that needs to be addressed at the trial design stage. A clinical trial that includes both a placebo group and a non-participating control arm is the most powerful design for separating the non-specific and polymorphic placebo effect from the specific effects of trial medication. The control variables in a trial of homeopathic medication should also include the process of consultation as this may assume a meaning for the individual that can also be associated with a placebo effect.
authors.affiliation: Barts and the London School of Medicine and Dentistry, Queen Mary University of London, William Harvey Research Institute, London, EC1M 6BQ, UK.
authors.forename: Claire
authors.initials: C
authors.lastname: Haresnape
references.citation: Perspect Biol Med. 2009 Autumn;52(4):518-39
references.pmid: 19855122
references.citation: J Altern Complement Med. 2010 Apr;16(4):347-55
references.pmid: 20423206
references.citation: J Altern Complement Med. 2012 May;18(5):445-53
references.pmid: 22594648
references.citation: BMJ. 1995 Aug 26;311(7004):551-3
references.pmid: 7663213
references.citation: Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1808-17
references.pmid: 21576138
references.citation: Patient Educ Couns. 2011 Sep;84(3):413-9
references.pmid: 21621366
references.citation: J Psychopharmacol. 2008 Jul;22(5):543-52
references.pmid: 18701641
references.citation: Homeopathy. 2004 Oct;93(4):179-85
references.pmid: 15532695
references.citation: Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1783-9
references.pmid: 21576135
references.citation: Neuropsychopharmacology. 2011 Jan;36(1):339-54
references.pmid: 20592717
references.citation: Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1870-8
references.pmid: 21576144
references.citation: Homeopathy. 2010 Apr;99(2):119-29
references.pmid: 20471615
references.citation: Rheumatology (Oxford). 2011 Jun;50(6):1070-82
references.pmid: 21076131
references.citation: Forsch Komplementmed. 2009 Apr;16(2):105-10
references.pmid: 19420956
references.citation: J Psychosom Res. 2001 Mar;50(3):155-60
references.pmid: 11316508
references.citation: Br J Clin Pharmacol. 1998 Jun;45(6):613
references.pmid: 9663820
references.citation: Homeopathy. 2011 Oct;100(4):203-11
references.pmid: 21962194
references.citation: Complement Ther Med. 2008 Feb;16(1):15-21
references.pmid: 18346624
references.citation: Cult Med Psychiatry. 2009 Mar;33(1):112-52
references.pmid: 19107582